Jagsonpal completes 77.21 percent acquisition of Aequitas Healthcare
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals has completed the acquisition of a 77.21 percent equity stake in Aequitas Healthcare Private Limited, which is lower than the originally planned 85 percent stake. The proposed acquisition was first disclosed on June 29, 2026 with an update on July 7, 2026. This filing under SEBI LODR Regulation 30 confirms a slightly scaled down version of the deal, expanding the company presence into the healthcare services space. Details on the remaining stake were not provided.
Stake acquired is below the originally planned 85 percent. Acquiring 77 percent control still gives meaningful strategic entry into healthcare services.